Please use this identifier to cite or link to this item: http://dspace.iitrpr.ac.in:8080/xmlui/handle/123456789/4601
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAroosa, M-
dc.contributor.authorMalik, J A-
dc.contributor.authorAhmed, S-
dc.contributor.authorBender, O-
dc.contributor.authorAhemad, N-
dc.contributor.authorAnwar, S-
dc.date.accessioned2024-06-12T14:13:25Z-
dc.date.available2024-06-12T14:13:25Z-
dc.date.issued2024-06-12-
dc.identifier.urihttp://dspace.iitrpr.ac.in:8080/xmlui/handle/123456789/4601-
dc.description.abstractAbstract Antiepileptic drugs are versatile drugs with the potential to be used in functional drug formulations with drug repurposing approaches. In the present review, we investigated the anticancer properties of antiepileptic drugs and interlinked cancer and epileptic pathways. Our focus was primarily on those drugs that have entered clinical trials with positive results and those that provided good results in preclinical studies. Many contributing factors make cancer therapy fail, like drug resistance, tumor heterogeneity, and cost; exploring all alternatives for efficient treatment is important. It is crucial to find new drug targets to find out new antitumor molecules from the already clinically validated and approved drugs utilizing drug repurposing methods. The advancements in genomics, proteomics, and other computational approaches speed up drug repurposing. This review summarizes the potential of antiepileptic drugs in different cancers and tumor progression in the brain. Valproic acid, oxcarbazepine, lacosamide, lamotrigine, and levetiracetam are the drugs that showed potential beneficial outcomes against different cancers. Antiepileptic drugs might be a good option for adjuvant cancer therapy, but there is a need to investigate further their efficacy in cancer therapy clinical trials.en_US
dc.language.isoen_USen_US
dc.subjectBreast canceren_US
dc.subjectAntiepileptic drugs for canceren_US
dc.subjectDrug repurposingen_US
dc.subjectCancer treatmenten_US
dc.subjectAntiepileptic drugsen_US
dc.titleThe evidence for repurposing anti-epileptic drugs to target canceren_US
dc.typeArticleen_US
Appears in Collections:Year-2023

Files in This Item:
File Description SizeFormat 
Full Text.pdf1.53 MBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.